Phase I study of BMS-214662, a farnesyl transferase inhibitor in patients with acute leukemias and high-risk myelodysplastic syndromes (Q45280570)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Phase I study of BMS-214662, a farnesyl transferase inhibitor in patients with acute leukemias and high-risk myelodysplastic syndromes |
scientific article |
Statements
1 reference
Phase I study of BMS-214662, a farnesyl transferase inhibitor in patients with acute leukemias and high-risk myelodysplastic syndromes (English)
1 reference
Razelle Kurzrock
1 reference
Hagop Kantarjian
1 reference
Alessandra Ferrajoli
1 reference
Stefan Faderl
1 reference
Susan O'Brien
1 reference
Francis Giles
1 reference
Guillermo Garcia-Manero
1 reference
Jorge Cortes
1 reference
Elihu Estey
1 reference
Deborah Thomas
1 reference
Miloslav Beran
1 reference
Charles Koller
1 reference
John Wright
1 reference
Stephen A Bai
1 reference
22 February 2005
1 reference
1 reference
Identifiers
1 reference